|
March 4, 2020 | AnalyticsDx™ Comprehensive is a new tool that arranges lab testing data into a visual dashboard that allows you to see your organization’s trends and provides customized recommendations. |
|
February 20, 2020 |
FDA Files ARUP Laboratories’ AAV5 CDx for Hemophilia A Gene Therapy Treatment ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP’s premarket approval application (PMA) for an AAV5 total antibody assay. |
|
February 18, 2020 |
ARUP Laboratories Contributes to Dramatically Shortening TAT for Neonatal Genetic Sequencing In collaboration with ARUP Laboratories’ genomic scientists and bioinformatitians, University of Utah Health announced a project with the goal of accurately detecting genetic disorders among newborns. |
|
February 5, 2020 | Kimberley Evason, MD, PhD, and Gregory Ducker, PhD, are two of only 12 scientists nationwide to receive the 2020 Damon-Runyon-Rachleff Innovation Award for their liver cancer research. |
|
December 10, 2019 |
We Have Outstanding News. Again! For the second year in a row, ARUP was honored with a Best Companies to Work for Award for 2019. This recognition falls on the heels of a Top Workplaces 2019 honor that ARUP received last month. Employee feedback via a third-party survey has earned ARUP all three awards. Eighty percent of employees must respond in order to qualify. ARUP was in a category for those companies whose workforce exceeds 2,500 employees. “High five your colleagues! Every employee |
|
November 20, 2019 |
ARUP Laboratories Announces Death of Co-Founder Dr. John M. Matsen, III, one of the founders of ARUP Laboratories, Inc., passed away on November 9, 2019. He was 86 years old. Dr. Matsen, a professor of pathology and microbiology, became the Director of Clinical Laboratories at the University of Utah (U of U) in 1974. He came to Utah from the University of Minnesota, where he served as the Director of Clinical Microbiology Laboratories. |


























